Rush Medical Center Home Page Information for healthcare Professionals Rush University
FIND A DOCTOR
PATIENT & VISTOR SERVICES
HEALTH INFORMATION
CLINICAL SERVICES
EVENTS & CLASSES
RUSH NEWS ROOM
CLINICAL TRIALS
RESEARCH AT RUSH
NURSING AT RUSH
WORK AT RUSH
GIVING TO RUSH

Bookmark This Page
Clinical Trails at Rush Study Of TYZEKA with Compensated Chronic Hepatitis B Virus Infection
Clinical Trial Protocol ID
08080803

Clinical Trial Investigator Name
Nikunj Shah

Clinical Trial Title

Study of TYZEKA in subjects of Black/African American or Hispanic/Latino origin with compensated chronic hepatitis B virus infection.



Clinical Trial Protocol Description

The purpose of this study is to estimate the proportion of patients who achieve non-detectable HBV DNA in black/Caribbean/African Americans and Hispanic/Latinos with compensated chronic hepatitis B during 24 weeks of treatment with telbivudine.



Clinical Trial Eligibility Criteria

You may be eligible to participate in this study if you:

  • Have documented compensated chronic Hepatitis B
  • Are black Caribbean, African-American and/or Hispanics/Latino

This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.





Contact Name Doris Yadav
Contact Phone (312) 563-3919
Contact E-mail clinical_trials@rush.edu
Promotional Information

Clinical Trials Home
Infectious Disease Trials
Study Of TYZEKA with Compensated Chronic Hepatitis B Virus Infection

   
Find a Doctor | Patient & Visitor Services | Health Information
Clinical Services | Events & Classes | Rush News Room | Clinical Trials
Research At Rush
Disclaimer | Privacy Statement | Site Map

© Rush University Medical Center, Chicago, Illinois